[go: up one dir, main page]

DK680887A - Quinolinforbindelse og farmaceutiske praeparater med indhold af en saadan forbindelse - Google Patents

Quinolinforbindelse og farmaceutiske praeparater med indhold af en saadan forbindelse

Info

Publication number
DK680887A
DK680887A DK680887A DK680887A DK680887A DK 680887 A DK680887 A DK 680887A DK 680887 A DK680887 A DK 680887A DK 680887 A DK680887 A DK 680887A DK 680887 A DK680887 A DK 680887A
Authority
DK
Denmark
Prior art keywords
connection
quinol
pharmaceutical preparations
preparations containing
pharmaceutical
Prior art date
Application number
DK680887A
Other languages
English (en)
Other versions
DK163429C (da
DK163429B (da
DK680887D0 (da
Inventor
Arthur Page Phillips
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK680887D0 publication Critical patent/DK680887D0/da
Publication of DK680887A publication Critical patent/DK680887A/da
Publication of DK163429B publication Critical patent/DK163429B/da
Application granted granted Critical
Publication of DK163429C publication Critical patent/DK163429C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Secondary Cells (AREA)
  • Carbon And Carbon Compounds (AREA)
DK680887A 1986-12-23 1987-12-22 Carbostyrilderivat og farmaceutisk acceptable salte deraf, saadanne forbindelser til anvendelse som positive inotropiske midler, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater, farmaceutiske praeparater indeholdende en saadan forbindelse, samt fremgangsmaade til forbindelsernes fremstilling DK163429C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8630702 1986-12-23
GB868630702A GB8630702D0 (en) 1986-12-23 1986-12-23 Quinoline compound

Publications (4)

Publication Number Publication Date
DK680887D0 DK680887D0 (da) 1987-12-22
DK680887A true DK680887A (da) 1988-06-24
DK163429B DK163429B (da) 1992-03-02
DK163429C DK163429C (da) 1992-07-20

Family

ID=10609475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK680887A DK163429C (da) 1986-12-23 1987-12-22 Carbostyrilderivat og farmaceutisk acceptable salte deraf, saadanne forbindelser til anvendelse som positive inotropiske midler, anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater, farmaceutiske praeparater indeholdende en saadan forbindelse, samt fremgangsmaade til forbindelsernes fremstilling

Country Status (22)

Country Link
US (1) US4937248A (da)
EP (1) EP0272910B1 (da)
JP (1) JPS63166866A (da)
KR (1) KR880007514A (da)
AT (1) ATE65993T1 (da)
AU (1) AU594220B2 (da)
CA (1) CA1318671C (da)
DE (1) DE3772015D1 (da)
DK (1) DK163429C (da)
ES (1) ES2029842T3 (da)
FI (1) FI90768C (da)
GB (1) GB8630702D0 (da)
GR (1) GR3002445T3 (da)
HU (1) HU196991B (da)
IE (1) IE60619B1 (da)
IL (1) IL84917A (da)
MX (1) MX9203788A (da)
MY (1) MY102277A (da)
NZ (1) NZ223036A (da)
PH (1) PH23448A (da)
PT (1) PT86448B (da)
ZA (1) ZA879615B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8820174D0 (en) * 1988-08-25 1988-09-28 Wellcome Found Quinoline compound
HUP0003647A3 (en) * 1997-09-24 2002-12-28 Orion Corp Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates
CA2378298A1 (en) 1999-08-27 2001-03-08 Lawrence G. Hamann 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
IL148045A0 (en) 1999-08-27 2002-09-12 Ligand Pharm Inc Androgen receptor modulator compounds and methods
PE20010647A1 (es) 1999-09-14 2001-06-23 Lilly Co Eli Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2004266160A1 (en) 2003-08-22 2005-03-03 Ligand Pharmaceuticals Incorporated 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP3366698A1 (en) 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
ES2981866T3 (es) 2013-06-05 2024-10-10 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclasa C, método de elaboración y uso de los mismos
EP3884935B1 (en) 2013-08-09 2023-06-14 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2616855A (en) * 1948-01-15 1952-11-04 Procter & Gamble Detergent composition
US4329347A (en) * 1978-02-17 1982-05-11 Boehringer Ingelheim Gmbh Cardiotonic and antithrombotic sulfur-containing derivatives of carbostyril
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
PT79699B (en) * 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
NZ212209A (en) * 1984-05-29 1988-08-30 Pfizer Quinolone derivatives and pharmaceutical compositions
US4760064A (en) * 1984-12-18 1988-07-26 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds, compositions containing same and processes for preparing same
US4845100A (en) * 1985-04-12 1989-07-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
EP0255134B1 (en) * 1986-07-31 1993-03-03 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same

Also Published As

Publication number Publication date
DE3772015D1 (de) 1991-09-12
DK163429C (da) 1992-07-20
IL84917A0 (en) 1988-06-30
US4937248A (en) 1990-06-26
PT86448B (pt) 1990-11-20
PH23448A (en) 1989-08-07
GB8630702D0 (en) 1987-02-04
ZA879615B (en) 1989-08-30
AU8293387A (en) 1988-06-23
ES2029842T3 (es) 1992-10-01
HU196991B (en) 1989-02-28
MY102277A (en) 1992-05-15
IL84917A (en) 1991-08-16
ATE65993T1 (de) 1991-08-15
FI90768C (fi) 1994-03-25
CA1318671C (en) 1993-06-01
IE873490L (en) 1988-06-23
GR3002445T3 (en) 1992-12-30
PT86448A (en) 1988-01-01
EP0272910B1 (en) 1991-08-07
FI90768B (fi) 1993-12-15
FI875666A0 (fi) 1987-12-22
IE60619B1 (en) 1994-07-27
AU594220B2 (en) 1990-03-01
HUT45984A (en) 1988-09-28
MX9203788A (es) 1992-07-01
DK163429B (da) 1992-03-02
NZ223036A (en) 1990-11-27
JPS63166866A (ja) 1988-07-11
KR880007514A (ko) 1988-08-27
DK680887D0 (da) 1987-12-22
EP0272910A1 (en) 1988-06-29
FI875666L (fi) 1988-06-24

Similar Documents

Publication Publication Date Title
DK680887D0 (da) Quinolinforbindelse og farmaceutiske praeparater med indhold af en saadan forbindelse
DK353385A (da) Fremstilling af 3-acylamino-1-hydroxy-2-azetidinoner og herved forekommende n-hydroxybeskyttelsesgrupper
DK0444659T3 (da) Farmaceutisk opløsning indeholdende derivater af FK 506
DE69132435D1 (de) Inhibitoren retroviraler Proteasen
DK426289D0 (da) Spiroforbindelser og farmaceutisk praeparat indeholdende en saadan forbindelse
DK43882A (da) Fremgangsmaade til fremstilling af cephemforbindelser
DE68905406D1 (de) Chinolin-verbindung.
DE3870954D1 (de) Zahnaerztliche haftmittelzusammensetzung.
ES8708136A1 (es) Procedimiento para la obtencion de derivados de acido barbiturico
DE3877036D1 (de) Biologisch aktive verbindungen.
ES2075137T3 (es) Compuestos sustituidos de piridina; su produccion y composiciones farmaceuticas que los contienen.
ATE60779T1 (de) N-glykolylneuraminsaeurederivat.
DK656889D0 (da) Hidtil ukendte forbindelser
DK535388D0 (da) Anvendelse af piperidinopropiophenonforbindelse til fremstilling af et hypotensivt middel
DK411989D0 (da) 7-(6-amino-2-azabicyclooe2.2.2aaoct-yl)-1,4-dihydro -6-fluor-4-oxo-3-quinolincarboxylsyre-forbindelser, farmaceutiske praeparater indeholdende disse og anvendelse af forbindelserne til fremstilling af antibakterielle laegemidler

Legal Events

Date Code Title Description
PBP Patent lapsed